ARVINAS, INC. Interest Expense
ARVINAS, INC. (ARVN) reported Interest Expense of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-08-06
- ARVINAS, INC. interest expense for the quarter ending 2025-06-30 was $0.00.
- ARVINAS, INC. interest expense for the quarter ending 2025-03-31 was $0.00.
- ARVINAS, INC. interest expense for the quarter ending 2024-12-31 was $0.00.
- ARVINAS, INC. interest expense for the quarter ending 2024-09-30 was $0.00.
- ARVINAS, INC. interest expense for fiscal 2024 was $0.00.
- ARVINAS, INC. interest expense for fiscal 2023 was $0.00.
- ARVINAS, INC. interest expense for fiscal 2022 was $0.00.
- ARVINAS, INC. interest expense for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-08-06 | $0.00 derived: sum of 4 quarters · filed 2025-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2025-05-01 | $0.00 derived: sum of 3 quarters · filed 2025-05-01 | $0.00 derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-06 | $0.00 10-K · filed 2025-02-11 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-08-06 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-08-06 | $0.00 derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2025-05-01 | $0.00 derived: sum of 3 quarters · filed 2025-05-01 | $0.00 derived: sum of 4 quarters · filed 2025-05-01 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 10-K · filed 2025-02-11 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 10-K · filed 2025-02-11 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | -$32.50K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | -$32.50K derived: sum of 3 quarters · filed 2024-02-27 | -$24.38K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-05 | -$32.50K derived: sum of 2 quarters · filed 2024-02-27 | -$24.38K derived: sum of 3 quarters · filed 2024-02-27 | -$16.25K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$32.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$24.38K derived: sum of 2 quarters · filed 2024-02-27 | -$16.25K derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | $100.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $8.13K 10-Q · filed 2021-11-03 | $16.25K derived: sum of 2 quarters · filed 2021-11-03 | $32.50K 10-Q · filed 2021-11-03 | $83.75K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2021-06-30 | $8.13K 10-Q · filed 2021-08-05 | $24.38K 10-Q · filed 2021-08-05 | $75.63K derived: sum of 3 quarters · filed 2022-02-28 | $91.88K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2021-03-31 | $16.25K 10-Q · filed 2021-05-04 | $67.50K derived: sum of 2 quarters · filed 2022-02-28 | $83.75K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-12-31 | $51.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $67.50K derived: sum of 2 quarters · filed 2022-02-28 | $83.75K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K 10-K · filed 2022-02-28 | $65.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $16.25K 10-Q · filed 2021-11-03 | $32.50K derived: sum of 2 quarters · filed 2021-11-03 | $48.75K 10-Q · filed 2021-11-03 | $65.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $16.25K 10-Q · filed 2021-08-05 | $32.50K 10-Q · filed 2021-08-05 | $48.75K derived: sum of 3 quarters · filed 2021-08-05 | $71.65K derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $16.25K 10-Q · filed 2021-05-04 | $32.50K derived: sum of 2 quarters · filed 2021-05-04 | $55.40K derived: sum of 3 quarters · filed 2021-05-04 | $78.18K derived: sum of 4 quarters · filed 2021-05-04 | |
| 2019-12-31 | $16.25K 10-K · filed 2020-03-16 | $39.15K derived: sum of 2 quarters · filed 2020-11-05 | $61.93K derived: sum of 3 quarters · filed 2020-11-05 | $100.00K 10-K · filed 2022-02-28 | $85.57K 10-K · filed 2020-03-16 |
| 2019-09-30 | $22.90K 10-Q · filed 2020-11-05 | $45.68K derived: sum of 2 quarters · filed 2020-11-05 | $69.32K 10-Q · filed 2020-11-05 | $93.95K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $22.78K 10-Q · filed 2020-08-04 | $46.42K 10-Q · filed 2020-08-04 | $71.05K derived: sum of 3 quarters · filed 2020-08-04 | $83.32K derived: sum of 4 quarters · filed 2020-08-04 | |
| 2019-03-31 | $23.64K 10-Q · filed 2020-04-28 | $48.27K derived: sum of 2 quarters · filed 2020-04-28 | $60.54K derived: sum of 3 quarters · filed 2020-04-28 | $70.41K derived: sum of 4 quarters · filed 2020-04-28 | |
| 2018-12-31 | $24.64K 10-K · filed 2020-03-16 | $36.90K derived: sum of 2 quarters · filed 2020-03-16 | $46.77K derived: sum of 3 quarters · filed 2020-03-16 | $57.44K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $12.26K 10-K · filed 2020-03-16 | $22.14K derived: sum of 2 quarters · filed 2020-03-16 | $32.80K 10-Q · filed 2019-11-04 | $44.26K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $9.87K 10-K · filed 2020-03-16 | $20.54K 10-Q · filed 2019-08-05 | $31.99K derived: sum of 3 quarters · filed 2020-03-16 | $44.21K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $10.67K 10-K · filed 2020-03-16 | $22.12K derived: sum of 2 quarters · filed 2020-03-16 | $34.34K derived: sum of 3 quarters · filed 2020-03-16 | $47.31K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $11.45K 10-K · filed 2019-03-26 | $23.67K derived: sum of 2 quarters · filed 2019-03-26 | $36.64K derived: sum of 3 quarters · filed 2019-03-26 | $50.36K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $12.22K 10-K · filed 2019-03-26 | $25.19K derived: sum of 2 quarters · filed 2019-03-26 | $38.91K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $12.97K 10-K · filed 2019-03-26 | $26.69K derived: sum of 2 quarters · filed 2019-03-26 | |||
| 2017-03-31 | $13.71K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |